CCR5 and HIV infectious disease: In addition, our investigation showed that sTLR2 directly interacts with HIV PAMPs, including p17, p24, and gp41, which leads to significantly reduced IL-8 production, CCR5 expression, NFκB activation, and HIV infection in a dose-dependent manner (55).